Here's Why You Should Hold Onto Cerner (CERN) Stock For Now
Zacks Investment Research | Sep 24, 2019 09:37PM ET
Cerner Corporation (NASDAQ:CERN) is expected to gain from positive developments and a strong guidance. However, softness in Technology Resale, Support and Maintenance and Reimbursed Travel units raises concern.
Price Performance
Over the past year, shares of the Zacks Rank #3 (Hold) company have rallied 6.8% against the industry ’s 10.1% decline.
For the trailing four quarters, Cerner has a positive average earnings surprise of 0.8%.
Let’s take a look at the factors that are currently favoring Cerner.
What’s Working for the Stock?
Strong View
For the third quarter of 2019, Cerner expects revenues between $1.41 billion and $1.46 billion. The mid-point of this range indicates growth of 7% from the prior-year quarter.
Adjusted earnings per share are anticipated between 65 cents and 67 cents. The mid-point of this range is 5% higher year over year.
Bookings are anticipated in the band of $1.50-$1.70 billion. The mid-point of this range indicates year-over-year improvement of 1% from the third quarter of 2018.
Cerner kept its 2019 revenue guidance intact. The company continues to expect revenues between $5.65 billion and $5.85 billion, the mid-point of which represents growth of 7% over 2018.
Cerner reiterated the 2019 earnings per share outlook as well. The company continues to project earnings of $2.64-$2.72, which indicates a rise of 9% at the mid-point.
Encouraging Developments
The company recently collaborated with GetWellNetwork, a global consumer health technology company, with a view to bridge the gap between providers and patients in inpatient and outpatient settings.
Last month, Cerner announced the development of the Cerner Learning Health Network to help clinicians gain health insights. Notably, the company has collaborated with the Duke Clinical Research Institute to pilot the initiative.
Deterrents
Cerner’s Technology Resale, Support and Maintenance and Reimbursed Travel segments have been seeing softness of late.
Technology resale revenues dropped 19.3% on a year-over-year basis, while Support and maintenance revenues were down 0.9%. Also, Reimbursed travel revenues reflected a decline of 4.9% year over year.
That’s not all. The company also witnessed a drop in long-term bookings.
Get The News You Want
Cerner Corporation Price and Consensus
Varian’s long-term earnings are expected to grow 8%.
CONMED’s long-term earnings are projected to increase 12.8%.
Masimo’s long-term earnings are estimated to rise 20.5%.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Original post
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.